Digest Network Come funziona
Network
/
Società
Jo
Non verificato

Johnson & Johnson

Di cosa scriviamo

BiotecnologiaFarmaceuticaSaluteSanitàWeb e Social Network

69 comunicati stampa

Guarda tutti i comunicati
02/03/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
18/02/2026
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
09/02/2026
Biotecnologia
Farmaceutica
Salute
Web e Social Network
Fiere
Eventi
Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
07/02/2026
Industria
Associazioni/Professionisti
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
02/02/2026
Biotecnologia
Farmaceutica
Salute
Eventi
Web e Social Network
Johnson & Johnson to Participate in the TD Cowen 46th Annual Health Care Conference
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
27/01/2026
Johnson & Johnson Marks $100 Million of MedTech Products Donated Since 2020 to Help People Live, See and Smile
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
21/01/2026
Cardiologia
Biotecnologia
Farmaceutica
Ottica
Oncologia
Salute
Medicina - Varie
Web e Social Network
Telefonia e Varie
Mercato azionario
Johnson & Johnson reports Q4 and Full-Year 2025 results
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
09/01/2026
Politica Interna
Salute
Sanità
Farmaceutica
Biotecnologia
Mercato del lavoro
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
07/01/2026
Salute
Igiene alimentare
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0
02/01/2026
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Titoli e azioni
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026
Fonte
Johnson & Johnson
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0